Chemours Current Deferred Revenue from 2010 to 2026

CC Stock  USD 14.84  0.27  1.79%   
Chemours' Current Deferred Revenue is increasing over the years with slightly volatile fluctuation. Overall, Current Deferred Revenue is expected to go to about 446.8 M this year. Current Deferred Revenue is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. View All Fundamentals
 
Current Deferred Revenue  
First Reported
2013-12-31
Previous Quarter
12 M
Current Value
M
Quarterly Volatility
19.8 M
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Chemours financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Chemours' main balance sheet or income statement drivers, such as Depreciation And Amortization of 311.8 M, Interest Expense of 157.1 M or Selling General Administrative of 786.3 M, as well as many indicators such as Price To Sales Ratio of 0.54, Dividend Yield of 0.0433 or PTB Ratio of 8.14. Chemours financial statements analysis is a perfect complement when working with Chemours Valuation or Volatility modules.
  
Build AI portfolio with Chemours Stock
Check out the analysis of Chemours Correlation against competitors.

Latest Chemours' Current Deferred Revenue Growth Pattern

Below is the plot of the Current Deferred Revenue of Chemours Co over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Chemours' Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Chemours' overall financial position and show how it may be relating to other accounts over time.
Current Deferred Revenue10 Years Trend
Slightly volatile
   Current Deferred Revenue   
       Timeline  

Chemours Current Deferred Revenue Regression Statistics

Arithmetic Mean112,310,294
Geometric Mean32,306,321
Coefficient Of Variation149.84
Mean Deviation136,827,509
Median20,000,000
Standard Deviation168,282,856
Sample Variance28319.1T
Range443.8M
R-Value0.74
Mean Square Error13566.1T
R-Squared0.55
Significance0.0006
Slope24,734,559
Total Sum of Squares453105.9T

Chemours Current Deferred Revenue History

2026446.8 M
2025425.5 M
2023370 M
202261 M
2021M
2019M
2018M

About Chemours Financial Statements

Chemours stakeholders use historical fundamental indicators, such as Chemours' Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although Chemours investors may analyze each financial statement separately, they are all interrelated. For example, changes in Chemours' assets and liabilities are reflected in the revenues and expenses on Chemours' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Chemours Co. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue425.5 M446.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out the analysis of Chemours Correlation against competitors.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Will Diversified Chemicals sector continue expanding? Could Chemours diversify its offerings? Factors like these will boost the valuation of Chemours. Projected growth potential of Chemours fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Chemours data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
(0.65)
Dividend Share
0.675
Earnings Share
(2.13)
Revenue Per Share
38.893
Quarterly Revenue Growth
(0.01)
Understanding Chemours requires distinguishing between market price and book value, where the latter reflects Chemours's accounting equity. The concept of intrinsic value—what Chemours' is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Chemours' price substantially above or below its fundamental value.
It's important to distinguish between Chemours' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Chemours should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Chemours' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.